Scott & Selber, Inc. Invitae Corp Transaction History

Scott & Selber, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 07, 2020	SELL	$15.02 - $20.57 $1.01 Million - $1.38 Million	-67,185 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$18.85 - $27.5 $1.27 Million - $1.85 Million	67,185 New	67,185 $1.3 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

Stay updated on Scott & Selber, Inc. with notifications on news.